Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (not Envue Medical, Inc.) on August 16, 2021. The filing announces the financial results for the second fiscal quarter ended June 30, 2021. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol NAOV.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the period.
Material Changes
The filing text does not contain specific data regarding material changes in financial performance compared to the prior comparable period. It only confirms the issuance of a press release containing these results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is NanoVibronix, Inc., as the input metadata incorrectly listed Envue Medical, Inc.
- Review Exhibit 99.1 (the Press Release dated August 16, 2021) to obtain actual revenue, net income, and cash flow figures.
- Confirm the specific trading symbol (NAOV) and exchange (Nasdaq Capital Market) for accurate market data retrieval.
- Note that this 8-K filing itself does not contain audited financial statements or detailed operational metrics.